BILR 355
BILR 355 is a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) . BILR 355 is highly specific toward HIV-1 reverse transcriptase (RT) . BILR 355 can be used for HIV infections research[1].
Product Specifications
CAS Number
380378-81-4
UNSPSC
12352005
Target
HIV; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bilr-355.html
Solubility
10 mM in DMSO
Smiles
CCN1C2=C(C=CC=N2)N(C(C3=CC(CCOC4=CC=[N+](C5=CC=CC=C54)[O-])=CN=C31)=O)C
Molecular Formula
C25H23N5O3
Molecular Weight
441.48
References & Citations
[1]Fenglei Huang, et al. Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers. Antimicrob Agents Chemother. 2008 Dec;52 (12) :4300-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
